13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Pierre D’Epenoux

CEO
FranceImcheck Therapeutics

Pierre d’Epenoux, Chief Executive Officer, brings to Imcheck Therapeutics over 20 years of international experience in strategic planning, corporate development and operational management with global pharmaceutical companies & biotech.

In 1995, Pierre founded & managed an Asian affiliate of Merck/Lipha in Vietnam-Laos-Cambodia. Four years later, he joined Merck KGaA in Darmstadt as director of Mergers & Acquisitions. In 2002, he joined Baxter Healthcare as Senior Director of Business Development where he led most of the global restructuring of the renal business.

In 2009, Pierre was appointed Head of Strategy & Business Development Europe at Sanofi, a position he held for four years before joining Theravectys, an emerging Paris-based biotech player developing lentiviral-vector based therapies as its Chief Strategy Officer.

Scroll to Top
  • No products in the cart.